Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP ...
Inari Medical has launched the Artix thrombectomy system, a medical device engineered specifically for certain requirements ...
Inari Medical announced the launch of its Artix thrombectomy system for arterial thromboembolism. According to the company, ...
The global Thrombectomy Devices Market, valued at US$ 1.7 billion in 2022, is projected to advance at a compound annual ...
Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the distinct needs of the peripheral ...
Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the distinct needs of the peripheral ...
However, existing therapies for arterial thromboembolism can lead to: The Artix System builds on the success of Inari's venous thrombectomy devices and is its inaugural entry into the arterial space.
Inari Medical, now part of Stryker , a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the distinct needs of the peripheral arterial ...
According to GlobalData, the worldwide thrombectomy device market was worth $2.96 billion in 2024 and is set to register a CAGR of 5.48 per cent from 2024 to 2034 ...